BCIQ Profiles

Company Profile Report
0708 ECP Xilis
BioCentury & Getty Images

Emerging Company Profile

Xilis: developing miniature cancer organoids

Emerging Company Profile: Xilis raises $70M led by Mubadala to advance tech for cancer drug development, treatment selection

With its $70 million series A round, Xilis will advance its miniature organoid technology to accelerate cancer drug development and guide treatment selection. 

Jul 9, 2021 | 12:50 AM GMT

Duke spinout

Read the full 597 word article

How to gain access

Continue reading with a
two-week free trial.